For H1 FY2026, revenue was 181,853 million yen, +6% year-over-year, and operating income was 36,335 million yen, +1% year-over-year. Growth contribution from international segments, expansion of solution-based orders, and monetization progress of AI-related investments are advancing. Order backlog stands at 36.4 hundred million yen, shortfall in overseas performance has narrowed, and digitalization efforts plus rollout of new functions such as AI agents continue.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2413","jir_company_name":"M3, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-04","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/2413-20261104-02.pdf","jir_short_summary":"For H1 FY2026, revenue was 181,853 million yen, +6% year-over-year, and operating income was 36,335 million yen, +1% year-over-year. Growth contribution from international segments, expansion of solution-based orders, and monetization progress of AI-related investments are advancing. Order backlog stands at 36.4 hundred million yen, shortfall in overseas performance has narrowed, and digitalization efforts plus rollout of new functions such as AI agents continue.","jir_summary":"### Overview of Results\nConsolidated results for the six months ended Q2 FY2026 show revenue of 181,853 million yen, +6% year-over-year, and operating income of 36,335 million yen, achieving growth over the prior period. Meanwhile, interim profit was 22,623 million yen, a decrease of -11% year-over-year. By segment, domestic Medical Platform, Evidence Solutions, and Site Solutions performed steadily. The international segment showed approximately +11% growth.\n\n### Outlook and Challenges\nOrder backlog is 36.4 hundred million yen, with expansion of solution-based orders compared with the prior year. We will promote the launch of new products including AI-enabled offerings and strengthen the sales organization. Digital transformation in clinical settings remains robust. We will continue to execute a medium-term growth strategy that expands international growth drivers while considering currency impact.","jir_financial_highlights":"Revenue: 181,853 (YoY +6%)\nOperating Income: 36,335 (YoY +1%)\nInterim Profit: 22,623 (YoY -11%)","jir_category":"","jir_hashtags":"#M3, #IRResults2026, #RevenueBySegment, #HealthcareDX","jir_key_figures":"Revenue: 181,853 million yen (YoY +6%)\nOperating Income: 36,335 million yen (YoY +1%)\nInterim Profit: 22,623 million yen (YoY -11%)","jir_meta_title":"M3, Inc. Q2 FY2026 Earnings | Revenue 18,185.3 million yen, YoY +6%","jir_meta_description":"Summary of M3, Inc.'s Q2 FY2026 consolidated results. Revenue was 18,185.3 million yen, +6% year-over-year, and operating income was 3,633.5 million yen. Discussion covers international business growth, progress on AI-related investments, and order backlog of 36.4 hundred million yen.","jir_og_title":"M3, Inc. | Q2 FY2026 Consolidated Results Overview and Growth Strategy","jir_og_description":"Analysis of H1 FY2026 revenue and profit trends, segment performance, international market growth, effects of AI-related investments, and future outlook.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025Q1\\\",\\\"FY2025Q2\\\",\\\"FY2026Q1\\\",\\\"FY2026Q2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[170885,181853,0,0]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025Q1\\\",\\\"FY2025Q2\\\",\\\"FY2026Q1\\\",\\\"FY2026Q2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[35992,36335,0,0]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Revenue by Segment\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Domestic MP\\\",\\\"ES\\\",\\\"CS\\\",\\\"SS\\\",\\\"PS\\\",\\\"International\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[5484,? , ?, ?, ?, 45000]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Margin Analysis\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025Q1\\\",\\\"FY2025Q2\\\",\\\"FY2026Q1\\\",\\\"FY2026Q2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Interim Profit Margin\\\",\\\"data\\\":[14.8,12.4,0,0]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Forecast vs Actual Comparison\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":{\\\"headers\\\":[\\\"Item\\\",\\\"FY2025Q1-2\\\",\\\"FY2026Q1-2\\\"],\\\"rows\\\":[[\\\"Revenue\\\",\\\"170,885\\\",\\\"181,853\\\"],[\\\"Operating Income\\\",\\\"35,992\\\",\\\"36,335\\\"]]}}\"}]","ir_related_company":7464,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-141099","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n